Vismodegib (Erivedge)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Vismodegib (Erivedge), covering 2018-05-11 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas [Phase 2]